Teva Pharmaceutical Industries (TEVA) EPS: History & Chart

Teva Pharmaceutical Industries Limited(TEVA)

Drug Manufacturers - Specialty & Generic · Tel Aviv, TA

$36.73-0.90 (-2.38%)

Delayed quote: Aug 28, 2026, 11:55 AM EDT

About Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited functions as a global pharmaceutical enterprise, involved in the conception, manufacturing, marketing, and provision of a broad spectrum of generic, specialty, and biopharmaceutical products throughout North America, Europe, and various international markets. The company's diverse product range includes sterile items, hormones, potent drugs, and cytotoxic agents, available in numerous forms like tablets, capsules, injectable solutions, inhalable preparations, liquids, transdermal patches, topical ointments, and creams. Additionally, Teva develops, produces, and sells active pharmaceutical ingredients (APIs). The firm prioritizes several key therapeutic domains: central nervous system disorders, pain management, respiratory ailments, and oncology. In the central nervous system sector, prominent products include Copaxone, intended for relapsing forms of multiple sclerosis; AJOVY, prescribed for preventing migraines; and AUSTEDO, which targets tardive dyskinesia and chorea linked to Huntington's disease. For respiratory conditions, Teva offers medications such as ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick, all designed to treat asthma and chronic obstructive pulmonary disease. The oncology portfolio features therapies like Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited is also engaged in a collaboration with MedinCell to advance and commercialize multiple long-acting injectable formulations, notably a risperidone suspension for individuals affected by schizophrenia. The company was established in 1901 and its primary headquarters are located in Tel Aviv-Yafo, Israel.

Tel Aviv, TA

32,008 employees

www.tevapharm.com

Healthcare / Drug Manufacturers - Specialty & Generic

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO: Richard D. Francis

View full financials

TEVA Earnings Per Share (EPS) Metrics

EARNINGS PER SHARE (EPS)

0.60

EARNINGS PER SHARE (EPS) AVG TTM

-0.11

EARNINGS PER SHARE (EPS) AVG 3Y

-0.73

EARNINGS PER SHARE (EPS) AVG 5Y

-1.03

EARNINGS PER SHARE (EPS) AVG 10Y

-2.12

EARNINGS PER SHARE (EPS) AVG 15Y

0.46

EARNINGS PER SHARE (EPS) AVG 20Y

0.75

CURRENT VS TTM AVG

+645.45%

CURRENT VS 3Y AVG

+182.19%

CURRENT VS 5Y AVG

+158.25%

CURRENT VS 10Y AVG

+128.31%

CURRENT VS 15Y AVG

+31.58%

CURRENT VS 20Y AVG

-19.62%

NAME	MARKET CAP	EARNINGS PER SHARE (EPS)	TTM	3Y	5Y
Teva Pharmaceutical Industries Limited (TEVA)	$42.82B	0.60	-0.11	-0.73	-1.03
IQVIA Holdings Inc. (IQV)vs ›	$43.10B	8.06	7.74	7.17	5.87
Agilent Technologies, Inc. (A)vs ›	$43.39B	5.08	4.52	4.36	3.96
IDEXX Laboratories, Inc. (IDXX)vs ›	$43.62B	14.12	11.97	10.56	9.63
Humana Inc. (HUM)vs ›	$46.95B	10.56	9.94	15.54	18.41
Alcon Inc. (ALC)vs ›	$34.95B	1.30	2.02	1.68	1.07
ResMed Inc. (RMD)vs ›	$34.73B	10.40	10.00	8.26	6.94
DexCom, Inc. (DXCM)vs ›	$34.14B	2.53	1.80	1.48	1.30
Edwards Lifesciences Corporation (EW)vs ›	$51.97B	1.74	4.41	3.40	2.89
Becton, Dickinson and Company (BDX)vs ›	$52.22B	3.32	5.86	5.65	5.38

NAME

MARKET CAP

EARNINGS PER SHARE (EPS)

TTM

Teva Pharmaceutical Industries Limited (TEVA)

$42.82B

0.60

-0.11

-0.73

-1.03

IQVIA Holdings Inc. (IQV)vs ›

$43.10B

8.06

7.74

7.17

5.87

Agilent Technologies, Inc. (A)vs ›

$43.39B

5.08

4.52

4.36

3.96

IDEXX Laboratories, Inc. (IDXX)vs ›

$43.62B

14.12

11.97

10.56

9.63

Humana Inc. (HUM)vs ›

$46.95B

10.56

9.94

15.54

18.41

Alcon Inc. (ALC)vs ›

$34.95B

1.30

2.02

1.68

1.07

ResMed Inc. (RMD)vs ›

$34.73B

10.40

10.00

8.26

6.94

DexCom, Inc. (DXCM)vs ›

$34.14B

2.53

1.80

1.48

1.30

Edwards Lifesciences Corporation (EW)vs ›

$51.97B

1.74

4.41

3.40

2.89

Becton, Dickinson and Company (BDX)vs ›

$52.22B

3.32

5.86

5.65

5.38

Earnings Per Share (EPS) FAQ

What is the earnings per share (EPS) for Teva Pharmaceutical Industries Limited (TEVA)?

The earnings per share (EPS) for TEVA stock is 0.60.

Is Teva Pharmaceutical Industries Limited's earnings per share (EPS) high or low?

The earnings per share (EPS) of 0.60 is 158% above its 5-year average of -1.03, near the high end of its 5-year range (-3.64–1.23).

What is the TTM average earnings per share (EPS) for Teva Pharmaceutical Industries Limited (TEVA)?

The TTM average earnings per share (EPS) for TEVA stock is -0.11.

What is the 3Y average earnings per share (EPS) for Teva Pharmaceutical Industries Limited (TEVA)?

The 3Y average earnings per share (EPS) for TEVA stock is -0.73.

What is the 5Y average earnings per share (EPS) for Teva Pharmaceutical Industries Limited (TEVA)?

The 5Y average earnings per share (EPS) for TEVA stock is -1.03.

What is the 10Y average earnings per share (EPS) for Teva Pharmaceutical Industries Limited (TEVA)?

The 10Y average earnings per share (EPS) for TEVA stock is -2.12.

What is the 15Y average earnings per share (EPS) for Teva Pharmaceutical Industries Limited (TEVA)?

The 15Y average earnings per share (EPS) for TEVA stock is 0.46.

What is the 20Y average earnings per share (EPS) for Teva Pharmaceutical Industries Limited (TEVA)?

The 20Y average earnings per share (EPS) for TEVA stock is 0.75.

DATE	EARNINGS PER SHARE (EPS)
2025-12-31	1.23
2024-12-31	-1.45
2023-12-31	-0.50
2022-12-31	-2.20
2021-12-31	0.38
2020-12-31	-3.64
2019-12-31	-0.92
2018-12-31	-2.11
2017-12-31	-16.01
2016-12-31	0.07
2015-12-31	1.84
2014-12-31	3.58
2013-12-31	1.49
2012-12-31	2.25
2011-12-31	3.10
2010-12-31	3.72
2009-12-31	2.29
2008-12-31	0.81
2007-12-31	2.54
2006-12-31	0.72
2005-12-31	1.73
2004-12-31	0.54
2003-12-31	1.29
2002-12-31	0.78
2001-12-31	0.53
2000-12-31	0.29
1999-12-31	0.24
1998-12-31	0.14
1997-12-31	0.21
1996-12-31	0.15

DATE

EARNINGS PER SHARE (EPS)

2025-12-31

1.23

2024-12-31

-1.45

2023-12-31

-0.50

2022-12-31

-2.20

2021-12-31

0.38

2020-12-31

-3.64

2019-12-31

-0.92

2018-12-31

-2.11

2017-12-31

-16.01

2016-12-31

0.07

2015-12-31

1.84

2014-12-31

3.58

2013-12-31

1.49

2012-12-31

2.25

2011-12-31

3.10

2010-12-31

3.72

2009-12-31

2.29

2008-12-31

0.81

2007-12-31

2.54

2006-12-31

0.72

2005-12-31

1.73

2004-12-31

0.54

2003-12-31

1.29

2002-12-31

0.78

2001-12-31

0.53

2000-12-31

0.29

1999-12-31

0.24

1998-12-31

0.14

1997-12-31

0.21

1996-12-31

0.15

Earnings Per Share (EPS): 0.60

TEVA Earnings Per Share (EPS)

TEVA Quarterly EPS Growth (YoY)

TEVA P/E Ratio

TEVA P/E Ratio Chart

TEVA Average Earnings Per Share (EPS) Chart

TEVA Current vs Average Earnings Per Share (EPS) Chart

TEVA Earnings Per Share (EPS) Metrics

TEVA Competitors' Earnings Per Share (EPS)

EPS Comparison

Earnings Per Share (EPS) Formula & Definition

Earnings Per Share (EPS) FAQ

TEVA Earnings Per Share (EPS) History

Related Metrics

TEVA PEG Ratio

TEVA PEG Ratio Chart